SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2E12753E3B9E5F91CF6C9461DD3C3FB257E2693EBD217DDC778934E7EA537347C63B0728119CF0C805581DE51A5FA82D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2E12753E3B9E5F91CF6C9461DD3C3FB257E2693EBD217DDC778934E7EA537347C63B0728119CF0C805581DE51A5FA82D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2E12753E3B9E5F91CF6C9461DD3C3FB257E2693EBD217DDC778934E7EA537347C63B0728119CF0C805581DE51A5FA82D
http://www.w3.org/2000/01/rdf-schema#comment
"Results characterize a novel immunosuppressant which shows potential anti-tumor effects on gastric cancer by PTEN activation through p53-independent mechanism especially in combination with Cisplatin."
xsd:string
http://purl.uniprot.org/uniprot/#_D413B2825A9723C79B8E5B8BCE450635BAFCA36B8742B89D4880CA7DC4291746560C2D66612DCECF0B056F5BB2E17AB3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2E12753E3B9E5F91CF6C9461DD3C3FB257E2693EBD217DDC778934E7EA537347C63B0728119CF0C805581DE51A5FA82D
http://purl.uniprot.org/uniprot/F6KCZ4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E12753E3B9E5F91CF6C9461DD3C3FB257E2693EBD217DDC778934E7EA537347C63B0728119CF0C805581DE51A5FA82D
http://purl.uniprot.org/uniprot/#_F6KCZ4-mappedCitation-20506484
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E12753E3B9E5F91CF6C9461DD3C3FB257E2693EBD217DDC778934E7EA537347C63B0728119CF0C805581DE51A5FA82D